Literature DB >> 3959895

Genetics of the spontaneous diabetic syndrome. Interaction of MHC and non-MHC-associated factors.

E Colle, R D Guttmann, A Fuks, T A Seemayer, G J Prud'homme.   

Abstract

The occurrence of the spontaneous insulin-dependent diabetic syndrome in the rat is the result of several genetic susceptibilities. There is a requirement for the u haplotype of the rat major histocompatibility complex (MHC), RT1. More specifically this requirement is for genes mapping to the right of the RT1 A locus, which codes for class I products. Furthermore, u haplotypes from inbred strains other than the BB rat can provide this permissive u haplotype. Diabetes occurs in animals with either one or two u haplotype and the diabetic syndrome is similar in its characteristics. In addition to the requirement for the MHC genes, there are abnormalities of the immune system of the various diabetes-prone strains, which are present in animals that develop overt disease. These abnormalities segregate independently of the RT1 and interaction between the susceptibilities is necessary for the manifestation of the complete clinical syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959895

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  3 in total

1.  The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats.

Authors:  John P Mordes; Jean Leif; Stephen Novak; Cheryl DeScipio; Dale L Greiner; Elizabeth P Blankenhorn
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

2.  Molecular characterization of MHC class II antigens (beta 1 domain) in the BB diabetes-prone and -resistant rat.

Authors:  N J Chao; L Timmerman; H O McDevitt; C O Jacob
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line in vitro following exposure to gamma interferon.

Authors:  B Issa-Chergui; A Goldner-Sauvé; E Colle; G J Prud'homme; P H Lapchak; P H van der Meide; T A Seemayer
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.